Cornerstone Financial Management’s Astria Therapeutics ATXS Stock Holding History

Cornerstone Financial Management’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-78	Closed	-$1.02K	–	1316
2025 Q4	$1.02K	Buy	+78	New	+$932	﹤0.01%	921

Cornerstone Financial Management's ATXS Position: Q1 2026 in Review

Cornerstone Financial Management sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 78 shares — an estimated $1.02K sold.

Cornerstone Financial Management first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $1.02K in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Cornerstone Financial Management reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Cornerstone Financial Management sold 78 Astria Therapeutics shares in Q1 2026, an estimated $1.02K.
Cornerstone Financial Management first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
Cornerstone Financial Management's Astria Therapeutics position peaked at $1.02K in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Cornerstone Financial Management's 13F filing for Q1 2026, filed 8 May 2026.